HomeCompareADOCY vs VICI

ADOCY vs VICI: Dividend Comparison 2026

ADOCY yields 16.95% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $905.8K in total portfolio value· pulled ahead in Year 5
10 years
ADOCY
ADOCY
● Live price
16.95%
Share price
$11.80
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$60.4K
Annual income
$4,795.20
Full ADOCY calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — ADOCY vs VICI

📍 VICI pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADOCYVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADOCY + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADOCY pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADOCY
Annual income on $10K today (after 15% tax)
$1,440.68/yr
After 10yr DRIP, annual income (after tax)
$4,075.92/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, VICI beats the other by $512,193.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADOCY + VICI for your $10,000?

ADOCY: 50%VICI: 50%
100% VICI50/50100% ADOCY
Portfolio after 10yr
$513.3K
Annual income
$306,085.66/yr
Blended yield
59.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

ADOCY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.6
Piotroski
5/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADOCY buys
0
VICI buys
0
No recent congressional trades found for ADOCY or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADOCYVICI
Forward yield16.95%6.52%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$60.4K$966.2K
Annual income after 10y$4,795.20$607,376.13
Total dividends collected$31.4K$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: ADOCY vs VICI ($10,000, DRIP)

YearADOCY PortfolioADOCY Income/yrVICI PortfolioVICI Income/yrGap
1$12,395$1,694.92$11,361$941.49+$1.0KADOCY
2$15,226$1,963.40$13,320$1,481.32+$1.9KADOCY
3$18,546$2,254.06$16,284$2,405.01+$2.3KADOCY
4$22,410$2,565.92$21,040$4,071.78+$1.4KADOCY
5← crossover$26,876$2,897.70$29,209$7,285.49$2.3KVICI
6$32,006$3,247.88$44,443$14,006.51$12.4KVICI
7$37,861$3,614.69$75,822$29,512.55$38.0KVICI
8$44,507$3,996.22$148,733$69,726.75$104.2KVICI
9$52,013$4,390.43$344,394$189,413.75$292.4KVICI
10$60,449$4,795.20$966,234$607,376.13$905.8KVICI

ADOCY vs VICI: Complete Analysis 2026

ADOCYStock

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform is designed and developed to optimize the performance of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes bi-hormonal products, which include BioChaperone AsPram, which is a combination of rapid insulin aspart with pramlintide; and BioChaperone Glargine Liraglutidea, which is a fixed combination of insulin glargine with an analogue of the GLP-1 receptor. In addition, the company's preclinical pipeline includes multihormonal products for the treatment of obesity, including BioChaperone GluExe, which is a combination of glucagon and exenatide; PramExe, which is a combination of pramlintide and exenatide; and BioChaperone PramGluExe, which is a triple combination of pramlintide, glucagon and exenatide. It has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. The company was incorporated in 2005 and is headquartered in Lyon, France.

Full ADOCY Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this ADOCY vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADOCY vs SCHDADOCY vs JEPIADOCY vs OADOCY vs KOADOCY vs MAINADOCY vs NNNADOCY vs EPRTADOCY vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.